KZIA

Kazia Therapeutics Ltd Sponsored ADR · NASDAQ

Sector Health Technology
Industry Biotechnology
Website kaziatherapeutics.com
Employees(FY) -
ISIN US48669G2049

Performance

-12.21%

+11.66%

+47.94%

+98.8%

+27.65%

YTD

-27.3%

Profile

Kazia Therapeutics Limited operates as a biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma, diffuse intrinsic pontine glioma/advanced solid tumors, atypical teratoid rhabdoid tumor, brain metastases, triple negative breast cancer, and primary central nervous system lymphoma. It is also developing EVT801, a small molecule targeted therapeutic vascular endothelial growth factor receptor 3 inhibitor. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.

Advanced Technical Analysis

Technical Analysis of KZIA 2024-11-20

The stock exhibits a bullish sentiment overall, driven by a strong Moving Average Score of 76, while the Oscillators Score of 43 indicates a neutral stance, and the Technical Score of 60 reinforces the positive outlook. This combination suggests a generally favorable market condition, although caution is warranted due to the weaker oscillator pe...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of KZIA

Stock Rank

Recent News & Updates

2024-11-03 18:30
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme(Prnewswire)
2024-10-15 19:27
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing(Yahoo Finance)
2024-10-14 19:32
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women(Prnewswire)
2024-10-01 20:45
Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients with Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American Society fo(Prnewswire)
2024-09-22 20:30
Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium(Prnewswire)
2024-09-11 19:30
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER(Prnewswire)
2024-07-30 21:53
7 Top Stocks Under $10: July 2024 Edition(Yahoo Finance)
2024-07-30 19:00
Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?(Yahoo Finance)
2024-07-24 18:10
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics(Yahoo Finance)
2024-07-11 23:24
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why(Zacks)
2024-07-11 22:08
From Pennies to Dollars: 3 Sub-$5 Stocks Set to Explode Higher(Investorplace)
2024-07-11 19:41
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-07-11 01:26
Silk Recalls 2024: What to Know as Plant-Based Milk Recalled Over Listeria Concerns(Investorplace)
2024-07-11 01:01
FCEL Stock Alert: FuelCell Energy Pops on Korean Market Update(Investorplace)
2024-07-11 00:51
JOBY Stock Pops After Completing 523-Mile eVTOL Flight(Investorplace)
2024-07-11 00:31
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains(Investorplace)
2024-07-10 19:29
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday(Investorplace)
2024-07-10 18:32
Kazia Therapeutics stocks soar following Phase II/III win(Yahoo Finance)
2024-07-10 00:42
KBW Just Cut Its Price Target on SoFi (SOFI) Stock(Investorplace)
2024-07-10 00:08
PLUG Stock: Plug Power Shares Hydrogen Refueling Station Update(Investorplace)
2024-07-09 23:57
Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?(Investorplace)
2024-07-09 19:30
Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma(Prnewswire)
2024-06-26 20:15
KAZIA ANNOUNCES UPCOMING DIPG DATA PRESENTATIONS AT ISPNO AND PUBLICATION IN EUROPEAN JOURNAL OF CANCER(Prnewswire)
2024-05-23 02:41
Kazia Granted 180-Day Extension by Nasdaq to Meet the Minimum Bid Price Requirement(Prnewswire)
2024-05-20 19:39
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-05-01 16:22
Kazia concludes first stage of Phase I advanced cancer treatment trial(Yahoo Finance)
2024-04-30 20:45
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS(Prnewswire)
2024-03-23 19:55
11 Best ASX Stocks To Buy Now(Insidermonkey)
2024-03-20 20:52
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases(Prnewswire)
2024-03-12 20:00
Kazia announces presentation of new data at AACR Annual Meeting(Prnewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.